Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
The American Journal of Surgical Pathology|December 4, 2024
Clinicopathologic Features of Breast Tumors in Germline TP53 Variant-Associated Li-Fraumeni SyndromeMohan Narasimhamurthy, Anh Le, Nabamita Boruah, et al.Cancer Immunology Research|June 21, 2022
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian CancerHeng Liu, Jianhuang Lin, Wei Zhou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
The biology of hypomorphic TP53 variants and implications for clinical managementRenyta Moses, Jacquelyn Powers, Alison S Levine, et al.Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.Nature Communications|May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.Pageof 1